Final Height of Patients with Turner's Syndrome Treated with Growth Hormone (GH): Indications for GH Therapy Alone at High Doses and Late Estrogen Therapy
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
We report final height data of patients with Turner's syndrome collected by the Italian Study Group for Turner's Syndrome. One hundred and thirty-five patients reached their final height during GH therapy with different therapeutic regimens (dose and combination). They were divided into 3 groups: group A, 74 patients with high doses of GH (1 IU/kg/week) for at least 2 yr; group A1, GH alone and estrogen therapy added not before 14 yr of chronological age (47 patients, of whom 30 were treated for >4 yr and 10 for >6 yr); group A2, GH plus ethinyl estradiol (17 patients) or GH plus oxandrolone (10 patients); group B, 51 patients with low doses of GH (0.5 IU/kg-week) and high doses of GH for less than 2 yr; and group C, 10 patients with high doses of GH with spontaneous menarche. In contrast to the patients of groups B and C, the patients of group A showed a significantly higher final height (mean, 147.5+/-6.5 cm) than their projected height (mean, 142.9+/-6.4 cm). They showed also a significantly higher final height compared to the subjects of groups B (mean, 145.6+/-5.7 cm) and C (mean, 143.0+/-5.3). Among the patients of group A, the best results were obtained in the patients of group A1 treated with GH alone at high doses and for a longer period (4 yr, 149.3+/-6.4 cm; 6 yr, 153.8+/-4.0 cm). Karyotype, GH secretion, and birth weight did not influence the efficacy of GH therapy. A low target height and a high prevalence of a spontaneous ovarian activity or menarche may negatively influence the effect of GH therapy. Estrogens did not improve final height when added to GH therapy. The use of small doses of oxandrolone was not effective in our experience. GH therapy provides a satisfactory auxological result, especially with high doses of GH alone, given for a long period of time. Optimization of the treatment would seem to require the identification of the ideal age for starting therapy, and this is only possible with a specially designed multicenter study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Growth hormone therapy of Turner's syndrome: beneficial effect on adult height
Rosenfeld, R. G., Attie, K. M., Frane, J., Brasel, A., Burstein, S., Cara, J. F., Chernausek, S., Gotlin, R. W., Kuntze, J., Lippe, B. M., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70452-4 · Cited by 265
Growth hormone secretory dynamics in Turner syndrome
Ross, J. L., Long, L. M., Loriaux, D. L., & Cutler, G. B. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80287-0 · Cited by 156 · cited 1×
“The study of growth factors in subjects with TS suggest a reduced secretion of GH, although at differing ages (19, 20).”
BackgroundBernasconi, S., Larizza, D., Benso, L., Volta, C., Vannelli, S., Milani, S., Aicardi (Genova), G., Berardi (Siena), R., Borrelli (Roma), P., Boscherini (Roma), B., et al. (1994) · Acta Paediatrica · doi:10.1111/j.1651-2227.1994.tb18097.x · Cited by 55
Self-citation
Cited by
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., Rogol, A. D., Lovejoy, J. C., Sheffield-Moore, M., Mauras, N., & Bowers, C. Y. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0038 · Cited by 452
Turner’s Syndrome in Adulthood
Elsheikh, M., Dunger, D. B., Conway, G. S., & Wass, J. A. H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0457 · Cited by 399
Gault, E. J., Perry, R. J., Cole, T. J., Casey, S., Paterson, W. F., Hindmarsh, P. C., Betts, P., Dunger, D. B., Donaldson, M. D. C., & on behalf of the British Society for Paediatric Endocrinology and Diabetes (2011) · BMJ · doi:10.1136/bmj.d1980 · Cited by 71
Labarta, J. I., Moreno, M. L., López-Siguero, J. P., Luzuriaga, C., Rica, I., Sánchez-del Pozo, J., & Gracia-Bouthelier, R. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0444 · Cited by 24
Bettendorf, M., Inta, I. M., Doerr, H. G., Hauffa, B. P., Mehls, O., & Ranke, M. B. (2013) · Hormone Research in Paediatrics · doi:10.1159/000356045 · Cited by 17
Metadata
- Authors
- Cacciari, E.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-12-01
- Volume
- 84
- Issue
- 12
- Pages
- 4510-4515
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2020475559
- Cited by
- 43
- References
- 3
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Final Height of Patients with Turner's Syndrome Treated with Growth Hormone (GH): Indications for GH Therapy Alone at High Doses and Late Estrogen Therapy. https://app.cochat.ai/papers/10.1210/jc.84.12.4510
- The paper
- Cacciari, E. (1999). Final Height of Patients with Turner's Syndrome Treated with Growth Hormone (GH): Indications for GH Therapy Alone at High Doses and Late Estrogen Therapy. Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.84.12.4510
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.